查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655716

兹卡病毒检测市场：全球产业分析、市场规模、份额、成长、趋势和未来预测（2025-2032 年）

Zika Virus Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 192 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球兹卡病毒检测市场的综合报告。该报告对关键市场动态进行了全面的评估，包括市场驱动因素、趋势、机会、驱动因素和挑战，并对市场结构提供了详细的见解。该报告提供了独家资料和统计数据，概述了 2025 年至 2032 年全球兹卡病毒检测市场的预期成长轨迹。

关键见解

  • 兹卡病毒检测市场规模（2025 年）：510 万美元
  • 市场规模预测（以金额为准，2032 年）：690 万美元
  • 全球市场成长率（CAGR，2025-2032）：4.3%

兹卡病毒检测市场：分析范围

兹卡病毒检测是兹卡病毒感染诊断和监测的关键组成部分，该病毒主要透过蚊虫叮咬传播，可导致新生儿严重的出生缺陷。该市场提供一系列诊断方法，包括分子测试（RT-PCR）、血清学测试（ELISA）和快速诊断套件，满足医院、诊断实验室和研究机构的需求。全球对蚊媒感染疾病的担忧日益加重，诊断技术的进步也推动了对可靠、有效的兹卡病毒检测解决方案的需求。

市场驱动因素：

全球兹卡病毒检测市场受到几个关键因素的推动，包括兹卡病毒感染疾病的盛行率不断上升，尤其是在热带和亚热带地区。政府针对疾病监测、早期检测和预防计划的措施进一步促进了市场的成长。诊断技术的进步，例如高灵敏度的 RT-PCR 检测和携带式快速检测套组的开发，将提高我们检测疾病的能力并确保及时介入和控制。此外，医疗专业人员和一般民众对兹卡病毒感染相关风险的认识不断提高，这也推动了对可靠诊断解决方案的需求。

市场限制：

儘管预计兹卡病毒检测市场将实现良好的成长，但它仍面临监管限制、市场发展地区医疗基础设施有限以及血清学检测交叉反应问题等挑战。对诊断测试核准的严格监管准则对市场进入和商业化构成了障碍。此外，分子检测成本高以及某些地区熟练实验室专业人员的短缺也对应用构成了挑战。解决这些问题需要增加政府资金、医疗保健和私人组织之间的合作以及对可负担的诊断解决方案的投资。

市场机会：

由于持续的研究和开发努力、不断扩大的医疗保健基础设施以及对全球卫生安全的日益关注，兹卡病毒检测市场提供了巨大的成长机会。人工智慧和机器学习融入诊断平台有望提高测试的准确性和效率。此外，为资源有限的环境开发经济高效且易于使用的照护现场（POC）检测套组为市场参与者创造了有利可图的机会。诊断公司和公共卫生机构之间的策略伙伴关係可以确保广泛获得先进的检测解决方案，并进一步促进市场扩张。

本报告回答的关键问题

  • 推动兹卡病毒检测市场全球成长的关键因素有哪些？
  • 哪些检测方法和应用领域在疾病检测和管理方面越来越受到关注？
  • 技术进步如何改变兹卡病毒检测市场的竞争格局？
  • 哪些主要企业对兹卡病毒检测市场做出了贡献？他们采用了什么策略来维持市场竞争力？
  • 全球兹卡病毒检测市场有哪些新兴趋势与未来前景？

目录

第一章执行摘要

第二章 市场概况

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
    • 全球医疗成本展望
  • COVID-19影响分析
  • 预测因子：相关性和影响力

第三章 加值分析

  • 依测试类型分析采用情况
  • 技术评估
  • 监管状态
  • 价值链分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第四章 价格趋势分析（2019-2032）

  • 主要亮点
  • 影响测试类型价格的关键因素
  • 定价分析：按测试类型
  • 按地区分類的价格和按测试类型分類的偏好

5. 全球兹卡病毒检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

  • 主要亮点
    • 市场规模预测（以数量为基础）
    • 市场规模及与前一年同期比较率（以金额为准（十亿美元））
    • 绝对商机
  • 市场规模分析及预测（以金额为准（十亿美元））
    • 历史市场规模分析（以金额为准（十亿美元），2019-2023 年）
    • 目前市场规模分析及预测（以金额为准（十亿美元），2025-2032）
  • 全球兹卡病毒检测市场前景（依检测类型）
    • 简介/主要发现
    • 按测试类型分類的历史市场规模分析（以金额为准（十亿美元），2019 年至 2023 年）
    • 按测试类型分類的当前市场规模分析和预测（以金额为准（十亿美元），2025 年至 2032 年）
      • 分子检测
        • RT-PCR
        • 其他基于 NAAT 的测试
      • 血清学检测
        • IgM抗体检测
        • 中和试验
        • 酵素免疫分析法（ELISA）
      • 其他类型的考试
        • 快速诊断测试 (RDT)
        • 多重测试
  • 按测试类型进行市场吸引力分析
  • 全球兹卡病毒检测市场应用前景
    • 简介/主要发现
    • 按应用分類的历史市场规模分析（以金额为准（十亿美元），2019 年至 2023 年）
    • 目前市场规模分析及应用预测（以金额为准（十亿美元），2025-2032）
      • 临床试验
      • 血液检查
      • 研究与开发
      • 产前检查
  • 按应用进行市场吸引力分析
  • 全球兹卡病毒检测市场前景（按最终用户）
    • 简介/主要发现
    • 按最终用户分類的历史市场规模分析（以金额为准（十亿美元），2019 年至 2023 年）
    • 目前市场规模分析及最终用户预测（以金额为准（十亿美元），2025-2032）
      • 医院和诊所
      • 诊断实验室
      • 血库
      • 研究所
      • 公共卫生机构
  • 最终用户的市场吸引力分析

6. 全球兹卡病毒检测市场区域展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（2019-2023）
  • 目前市场规模分析及各区域预测（2025-2032）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 按地区分析市场吸引力

7. 北美寨兹卡病毒检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

8. 欧洲兹卡病毒检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 9兹卡病毒。

第 10兹卡病毒。

第 11 章拉丁美洲寨兹卡病毒检测市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 12兹卡病毒。

第十三章 竞争格局

  • 市场占有率分析（2025年）
  • 市场结构
    • 竞争力地图：按市场
    • 竞争仪錶板
  • 公司简介（详情：概述、财务状况、策略、最新发展）
    • Abbott Laboratories
    • Altona Diagnostics GmbH
    • ChemBio Diagnostics Inc
    • ELITechGroup F
    • Hoffmann-La Roche Ltd
    • Genekam
    • DiaSorin（Luminex Corporation）
    • Novacyt Group

第十四章 附录

  • 分析方法
  • 分析前提条件
  • 首字母缩写和简称
简介目录
Product Code: PMRREP35097

Persistence Market Research has recently released a comprehensive report on the worldwide market for Zika virus testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global Zika virus testing market from 2025 to 2032.

Key Insights:

  • Zika Virus Testing Market Size (2025E):US$ 5.1 Mn
  • Projected Market Value (2032F): US$ 6.9 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 4.3%

Zika Virus Testing Market - Report Scope:

Zika virus testing is a critical component in the diagnosis and surveillance of Zika virus infections, which are primarily transmitted through mosquito bites and can lead to severe birth defects in newborns. The market includes various diagnostic methods, such as molecular tests (RT-PCR), serological tests (ELISA), and rapid diagnostic kits, catering to hospitals, diagnostic laboratories, and research institutions. The rising global concern over mosquito-borne diseases, coupled with advancements in diagnostic technology, is driving the demand for reliable and efficient Zika virus testing solutions.

Market Growth Drivers:

The global Zika virus testing market is propelled by several key factors, including the increasing prevalence of Zika virus outbreaks, particularly in tropical and subtropical regions. Government initiatives for disease surveillance, early detection, and prevention programs further contribute to market growth. Technological advancements in diagnostic techniques, such as the development of highly sensitive RT-PCR assays and portable rapid testing kits, enhance disease detection capabilities, ensuring timely intervention and containment. Additionally, rising awareness among healthcare professionals and the general population regarding the risks associated with Zika virus infections fuels the demand for reliable diagnostic solutions.

Market Restraints:

Despite promising growth prospects, the Zika virus testing market faces challenges related to regulatory constraints, limited healthcare infrastructure in developing regions, and cross-reactivity issues in serological testing. Stringent regulatory guidelines governing diagnostic test approvals impose barriers for market entry and product commercialization. Furthermore, the high cost of molecular testing methods and the lack of skilled laboratory professionals in certain regions pose challenges for widespread adoption. Addressing these issues requires increased government funding, collaborations between healthcare agencies and private organizations, and investment in affordable diagnostic solutions.

Market Opportunities:

The Zika virus testing market presents significant growth opportunities driven by continuous research and development efforts, expansion of healthcare infrastructure, and increased focus on global health security. The integration of artificial intelligence and machine learning in diagnostic platforms is expected to enhance test accuracy and efficiency. Additionally, the development of cost-effective and easy-to-use point-of-care (POC) testing kits for resource-limited settings presents lucrative opportunities for market players. Strategic partnerships between diagnostic companies and public health organizations can further facilitate market expansion, ensuring broader access to advanced testing solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Zika virus testing market globally?
  • Which testing methods and applications are gaining traction in disease detection and management?
  • How are technological advancements reshaping the competitive landscape of the Zika virus testing market?
  • Who are the key players contributing to the Zika virus testing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global Zika virus testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global Zika virus testing market, including Abbott Laboratories, Thermo Fisher Scientific, Bio-Rad Laboratories, and Roche Diagnostics, focus on innovation, product development, and strategic collaborations to maintain a competitive edge. These companies invest heavily in research and development to introduce advanced molecular diagnostic solutions, rapid testing kits, and high-throughput laboratory-based assays. Collaborations with government agencies, non-profit organizations, and research institutions facilitate the deployment of testing solutions in outbreak-prone regions. Moreover, emphasis on regulatory approvals, compliance with international health standards, and expansion into emerging markets contribute to the sustained growth of key market players.

Key Companies Profiled:

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Quest Diagnostics
  • Siemens Healthineers
  • PerkinElmer, Inc.
  • Becton, Dickinson and Company
  • Luminex Corporation
  • Hologic, Inc.

Zika Virus Testing Market Segmentation

By Test Type

  • Molecular Testing
  • Serological Testing
  • Other Testing Types

By Application

  • Clinical Testing
  • Blood Screening
  • Research and Development
  • Prenatal Testing

By End Use

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Blood Banks
  • Research Institutes
  • Public Health Organizations

By Region

  • North America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Zika Virus Testing Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Test Type Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019 - 2032

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Test Type Prices
  • 4.3. Pricing Analysis, By Test Type
  • 4.4. Regional Prices and Test Type Preferences

5. Global Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019 - 2024
    • 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
  • 5.3. Global Zika Virus Testing Market Outlook: Test Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019 - 2024
    • 5.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
      • 5.3.3.1. Molecular Testing
        • 5.3.3.1.1. RT-PCR
        • 5.3.3.1.2. Other NAAT-based tests
      • 5.3.3.2. Serological Testing
        • 5.3.3.2.1. IgM Antibody Testing
        • 5.3.3.2.2. Neutralization Assays
        • 5.3.3.2.3. Enzyme-Linked Immunosorbent Assay (ELISA)
      • 5.3.3.3. Other Testing Types
        • 5.3.3.3.1. Rapid Diagnostic Tests (RDTs)
        • 5.3.3.3.2. Multiplex Tests
  • 5.4. Market Attractiveness Analysis: Test Type
  • 5.5. Global Zika Virus Testing Market Outlook: Application
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
    • 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      • 5.5.3.1. Clinical Testing
      • 5.5.3.2. Blood Screening
      • 5.5.3.3. Research & Development
      • 5.5.3.4. Prenatal Testing
  • 5.6. Market Attractiveness Analysis: Application
  • 5.7. Global Zika Virus Testing Market Outlook: End Users
    • 5.7.1. Introduction / Key Findings
    • 5.7.2. Historical Market Size (US$ Mn) Analysis, By End Users, 2019 - 2024
    • 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
      • 5.7.3.1. Hospitals and Clinics
      • 5.7.3.2. Diagnostic Laboratories
      • 5.7.3.3. Blood Banks
      • 5.7.3.4. Research Institutes
      • 5.7.3.5. Public Health Organizations
  • 5.8. Market Attractiveness Analysis: End Users

6. Global Zika Virus Testing Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 7.3.1. By Country
    • 7.3.2. By Test Type
    • 7.3.3. By Application
    • 7.3.4. By End Users
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 7.4.1. U.S.
    • 7.4.2. Canada
  • 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
    • 7.5.1. Molecular Testing
    • 7.5.2. Serological Testing
    • 7.5.3. Other Testing Types
  • 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 7.6.1. Clinical Testing
    • 7.6.2. Blood Screening
    • 7.6.3. Research & Development
    • 7.6.4. Prenatal Testing
  • 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
    • 7.7.1. Hospitals and Clinics
    • 7.7.2. Diagnostic Laboratories
    • 7.7.3. Blood Banks
    • 7.7.4. Research Institutes
    • 7.7.5. Public Health Organizations
  • 7.8. Market Attractiveness Analysis

8. Europe Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 8.3.1. By Country
    • 8.3.2. By Test Type
    • 8.3.3. By Application
    • 8.3.4. By End Users
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. U.K.
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Turkey
    • 8.4.8. Rest of Europe
  • 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
    • 8.5.1. Molecular Testing
    • 8.5.2. Serological Testing
    • 8.5.3. Other Testing Types
  • 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 8.6.1. Clinical Testing
    • 8.6.2. Blood Screening
    • 8.6.3. Research & Development
    • 8.6.4. Prenatal Testing
  • 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
    • 8.7.1. Hospitals and Clinics
    • 8.7.2. Diagnostic Laboratories
    • 8.7.3. Blood Banks
    • 8.7.4. Research Institutes
    • 8.7.5. Public Health Organizations
  • 8.8. Market Attractiveness Analysis

9. East Asia Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 9.3.1. By Country
    • 9.3.2. By Test Type
    • 9.3.3. By Application
    • 9.3.4. By End Users
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
  • 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
    • 9.5.1. Molecular Testing
    • 9.5.2. Serological Testing
    • 9.5.3. Other Testing Types
  • 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 9.6.1. Clinical Testing
    • 9.6.2. Blood Screening
    • 9.6.3. Research & Development
    • 9.6.4. Prenatal Testing
  • 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
    • 9.7.1. Hospitals and Clinics
    • 9.7.2. Diagnostic Laboratories
    • 9.7.3. Blood Banks
    • 9.7.4. Research Institutes
    • 9.7.5. Public Health Organizations
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 10.3.1. By Country
    • 10.3.2. By Test Type
    • 10.3.3. By Application
    • 10.3.4. By End Users
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 10.4.1. India
    • 10.4.2. Southeast Asia
    • 10.4.3. ANZ
    • 10.4.4. Rest of South Asia & Oceania
  • 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
    • 10.5.1. Molecular Testing
    • 10.5.2. Serological Testing
    • 10.5.3. Other Testing Types
  • 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 10.6.1. Clinical Testing
    • 10.6.2. Blood Screening
    • 10.6.3. Research & Development
    • 10.6.4. Prenatal Testing
  • 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
    • 10.7.1. Hospitals and Clinics
    • 10.7.2. Diagnostic Laboratories
    • 10.7.3. Blood Banks
    • 10.7.4. Research Institutes
    • 10.7.5. Public Health Organizations
  • 10.8. Market Attractiveness Analysis

11. Latin America Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 11.3.1. By Country
    • 11.3.2. By Test Type
    • 11.3.3. By Application
    • 11.3.4. By End Users
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
    • 11.5.1. Molecular Testing
    • 11.5.2. Serological Testing
    • 11.5.3. Other Testing Types
  • 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 11.6.1. Clinical Testing
    • 11.6.2. Blood Screening
    • 11.6.3. Research & Development
    • 11.6.4. Prenatal Testing
  • 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
    • 11.7.1. Hospitals and Clinics
    • 11.7.2. Diagnostic Laboratories
    • 11.7.3. Blood Banks
    • 11.7.4. Research Institutes
    • 11.7.5. Public Health Organizations
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Zika Virus Testing Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
    • 12.3.1. By Country
    • 12.3.2. By Test Type
    • 12.3.3. By Application
    • 12.3.4. By End Users
  • 12.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
    • 12.4.1. GCC Countries
    • 12.4.2. Egypt
    • 12.4.3. South Africa
    • 12.4.4. Northern Africa
    • 12.4.5. Rest of Middle East & Africa
  • 12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025 - 2032
    • 12.5.1. Molecular Testing
    • 12.5.2. Serological Testing
    • 12.5.3. Other Testing Types
  • 12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    • 12.6.1. Clinical Testing
    • 12.6.2. Blood Screening
    • 12.6.3. Research & Development
    • 12.6.4. Prenatal Testing
  • 12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End Users, 2025 - 2032
    • 12.7.1. Hospitals and Clinics
    • 12.7.2. Diagnostic Laboratories
    • 12.7.3. Blood Banks
    • 12.7.4. Research Institutes
    • 12.7.5. Public Health Organizations
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Abbott Laboratories
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Test Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Altona Diagnostics GmbH
    • 13.3.3. ChemBio Diagnostics Inc
    • 13.3.4. ELITechGroup F
    • 13.3.5. Hoffmann-La Roche Ltd
    • 13.3.6. Genekam
    • 13.3.7. DiaSorin (Luminex Corporation)
    • 13.3.8. Novacyt Group

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations